Compare CIM & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CIM | IART |
|---|---|---|
| Founded | 2007 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2007 | 1996 |
| Metric | CIM | IART |
|---|---|---|
| Price | $11.68 | $16.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $15.25 | $14.33 |
| AVG Volume (30 Days) | ★ 708.8K | 529.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 10.92% | N/A |
| EPS Growth | ★ 56.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.62 | $4.39 |
| Revenue Next Year | $2.48 | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.30 | $8.70 |
| 52 Week High | $14.80 | $20.49 |
| Indicator | CIM | IART |
|---|---|---|
| Relative Strength Index (RSI) | 41.14 | 42.13 |
| Support Level | $11.46 | $16.04 |
| Resistance Level | $13.73 | $18.78 |
| Average True Range (ATR) | 0.16 | 0.61 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 49.18 | 13.77 |
Chimera Investment Corporation is an internally managed REIT whose principal business objective is to provide attractive risk-adjusted returns and distributable income through investment performance linked to mortgage credit fundamentals. Through its mortgage lending, investment management, and advisory services platforms, the Company operates as a fully integrated mortgage business that originates, manages, and invests in a diversified range of mortgage assets. The Company invests, directly or indirectly, generally on a levered basis across a spectrum of mortgage assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, Agency CMBS, MSRs, business purpose and investor loans, including RTLs, and other real estate-related assets.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.